Promisia shares tumble on Medsafe warning but company stands by product

Promisia shares tumble on Medsafe warning but company stands by product
Rebecca Howard
By Rebecca Howard Feb. 20 (BusinessDesk) - Promisia Integrative shares slumped 72 percent after Medsafe warned its Arthrem product could cause potential liver damage. The company said the number of reported cases is "extremely small" and it stands by its product.  On Monday, MedSafe said the Centre for Adverse Reactions Monitoring (CARM) received 20 notifications between February 2016 and December 31, 2017, 14 of which described harm to the liver.  Arthrem is a dietary supplement for joint support for humans. The proprietary extract made...